688626 翔宇医疗
2025/03 - 三个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入186,04810.02%743,531744,810488,529523,496
减:营业总成本174,61632.23%656,508529,660414,020358,786
    其中:营业成本64,55222.43%242,253233,715164,762166,316
               财务费用2,136-144.17%(23,715)(29,813)(26,644)(23,977)
               资产减值损失(1,424)2.59%(9,189)(12,117)(5,952)(2,777)
公允价值变动收益------------
投资收益422-58.61%1,4019,29313,65212,125
    其中:对联营企业和合营企业的投资收益(80)-55.08%62(540)(2,062)(1,840)
营业利润25,942-38.54%108,513244,629135,463224,059
利润总额25,190-40.35%107,235244,031132,992222,721
减:所得税费用2,818-19.52%4,38215,7179,69723,182
净利润22,372-42.23%102,853228,314123,295199,539
减:非控股权益(579)66.42%(90)1,171(2,175)(2,359)
股东净利润22,951-41.26%102,944227,143125,470201,897

市场价值指针
每股收益 (元) *0.150-40.00%0.6601.4400.7901.350
每股派息 (元) *----0.2400.5300.2400.380
每股净资产 (元) *12.708-2.15%12.74213.06812.04712.094
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容